SK278546B6 - Pharmaceutical composition for healing autoimmune deseases - Google Patents

Pharmaceutical composition for healing autoimmune deseases Download PDF

Info

Publication number
SK278546B6
SK278546B6 SK1227-92A SK122792A SK278546B6 SK 278546 B6 SK278546 B6 SK 278546B6 SK 122792 A SK122792 A SK 122792A SK 278546 B6 SK278546 B6 SK 278546B6
Authority
SK
Slovakia
Prior art keywords
compound
pharmaceutical composition
formula
autoimmune diseases
treatment
Prior art date
Application number
SK1227-92A
Other languages
English (en)
Slovak (sk)
Inventor
Bruno Silvestrini
Original Assignee
Bruno Silvestrini
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bruno Silvestrini filed Critical Bruno Silvestrini
Publication of SK278546B6 publication Critical patent/SK278546B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
SK1227-92A 1991-04-22 1992-04-22 Pharmaceutical composition for healing autoimmune deseases SK278546B6 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI911101A IT1253703B (it) 1991-04-22 1991-04-22 Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie

Publications (1)

Publication Number Publication Date
SK278546B6 true SK278546B6 (en) 1997-09-10

Family

ID=11359721

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1227-92A SK278546B6 (en) 1991-04-22 1992-04-22 Pharmaceutical composition for healing autoimmune deseases

Country Status (16)

Country Link
US (1) US5278183A (fr)
EP (1) EP0510748B1 (fr)
JP (1) JP3056879B2 (fr)
KR (1) KR100210199B1 (fr)
AT (1) ATE135573T1 (fr)
AU (1) AU657524B2 (fr)
BG (1) BG61366B2 (fr)
CA (1) CA2066304C (fr)
CZ (1) CZ280613B6 (fr)
DE (1) DE69209128T2 (fr)
DK (1) DK0510748T3 (fr)
IL (1) IL101660A (fr)
IT (1) IT1253703B (fr)
NZ (1) NZ242392A (fr)
SK (1) SK278546B6 (fr)
ZA (1) ZA922740B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723315B1 (fr) * 1994-08-02 1996-10-25 Cird Galderma Procede et composition pour stimuler la differenciation des cellules preadipocytaires et traitements therapeutiques associes
IT1276031B1 (it) * 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
IT1293795B1 (it) 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
EP1448557A4 (fr) * 2001-10-26 2005-02-02 Univ Connecticut Heteroindanes: nouvelle classe de ligands cannabimimetiques efficaces
ITMI20062254A1 (it) 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
AU2009221063B2 (en) 2008-03-07 2013-03-21 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, and CX3CR1
LT2254869T (lt) 2008-03-07 2017-08-10 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. Nauji 1-benzil-3-hidroksimetilindazolo dariniai ir jų panaudojimas gydyme ligų, susijusių su cx3cr1 ir p40 raiška
US8461194B2 (en) 2008-03-07 2013-06-11 Aziende Chimiche Riunite Angelini Francesco A. C. R. A. F. S. P. A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and P40
MX2012001520A (es) 2009-08-03 2012-06-01 Acraf Proceso para la preparacion de 1-bencil-3-hidroximetil-1h-indazol y sus derivados e intermediarios de magnesio requeridos.
UA108742C2 (uk) * 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
WO2020261158A1 (fr) 2019-06-25 2020-12-30 Translatum Medicus Inc. Procédés de fabrication d'acide 2-((1-benzyl-1h-indazol-3-yl)méthoxy)-2-méthylpropanoïque et de ses dérivés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1194564B (it) * 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
EP0191520B1 (fr) * 1985-02-12 1989-06-21 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. Acide(phénylméthyl-1 hydroxy-5 1H-indazolyl-3)oxyacétique et ses sels utiles comme médicaments et compositions pharmaceutiques les contenant
IT1230441B (it) * 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo

Also Published As

Publication number Publication date
EP0510748A1 (fr) 1992-10-28
CS122792A3 (en) 1992-11-18
CA2066304C (fr) 2005-06-21
BG61366B2 (bg) 1997-06-30
NZ242392A (en) 1997-06-24
IL101660A (en) 1996-08-04
CA2066304A1 (fr) 1992-10-23
IT1253703B (it) 1995-08-23
ATE135573T1 (de) 1996-04-15
DE69209128D1 (de) 1996-04-25
AU1488392A (en) 1992-10-29
ITMI911101A1 (it) 1992-10-22
KR920019350A (ko) 1992-11-19
ITMI911101A0 (it) 1991-04-22
DK0510748T3 (da) 1996-07-22
JPH0640915A (ja) 1994-02-15
DE69209128T2 (de) 1996-11-28
KR100210199B1 (ko) 1999-07-15
CZ280613B6 (cs) 1996-03-13
AU657524B2 (en) 1995-03-16
ZA922740B (en) 1992-12-30
US5278183A (en) 1994-01-11
EP0510748B1 (fr) 1996-03-20
JP3056879B2 (ja) 2000-06-26

Similar Documents

Publication Publication Date Title
Hollister Cannabidiol and cannabinol in man
SK278546B6 (en) Pharmaceutical composition for healing autoimmune deseases
Adeyeye et al. Diclofenac sodium
Ham et al. Studies on the mode of action of non-steroidal anti-inflammatory agents
Green The anti-inflammatory effect of catecholamines in the peritoneal cavity and hind paw of the mouse
US20100222376A1 (en) Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders
Doherty et al. The role of prostaglandins in the nociceptive response induced by intraperitoneal injection of zymosan in mice
PT688215E (pt) 3,4-diarilcromanos para o tratamento de dermatite
JPH07504915A (ja) ムスカリン拮抗物質投与による，哺乳動物の眼における眼内圧低下法
Filderman et al. Anti-inflammatory activity of the steroid alkaloid glycoside, tomatine
US5475033A (en) Anti-allergic pharmaceutical composition for ophthalmic topical administration
US3157655A (en) Pyrazolopyrimidine derivative
Megel et al. The anti-inflammatory actions of tilorone hydrochloride
YAMADA et al. Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs
Shen Non-steroidal anti-inflammatory agents
Ellis et al. Dibenamine blockade of epinephrine and glucagon hyperkalemias.
Mulqueen et al. Oral, anti-inflammatory activity of a potent, selective, protein kinase C inhibitor
JPS6263520A (ja) 抗リウマチ剤
US20060287353A1 (en) Method for preventing or treating ischemia-or hemorrhage-induced brain damage using a macrolide compound
KR100286141B1 (ko) 6,7-치환-2-아미노테트랄린을 함유한 패혈성 쇼크 치료용 및 해열, 소염용 의약 조성물
WONG et al. Pharmacological profiles of 5-phenylmethylenehydantoin and its methoxy substituted derivatives
HU219406B (hu) Eljárás autoimmun betegségek kezelésére alkalmas, benzil-indazol-származékokat tartalmazó gyógyszerkészítmények előállítására
RU2160102C2 (ru) Применение бензидамина для лечения патологических состояний, вызванных фно
US3193458A (en) Method of lowering blood cholesterol level
Kabara Brain cholesterol XVIII: EFFECt of methylphenidate (Ritalin) on [U-14C] glucose and [2-3H] acetate incorporation

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20120422